Genmab (GMAB) files Form 6-K on insider share transactions

Genmab A/S filed a Form 6-K as a foreign private issuer to furnish a company announcement related to insider dealing disclosures.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

6-K

Rhea-AI Filing Summary

Genmab A/S filed a Form 6-K as a foreign private issuer to furnish a company announcement related to insider dealing disclosures. The filing incorporates this update by reference into several existing Form S-8 registration statements for the company’s equity compensation plans, meaning the information becomes part of those registration documents. The attached exhibit covers transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 11/19/2025 - 02:35 PM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE MONTH OF NOVEMBER 2025

COMMISSION FILE NUMBER 001-38976

Genmab A/S
(Exact name of Registrant as specified in its charter)

Carl Jacobsens Vej 30

2500 Valby

Denmark

+45 70 20 27 28
(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F Form 40-F

This report on Form 6-K shall be deemed to be incorporated by reference in Genmab A/S’s registration statements on Form S-8 (File No. 333-232693, 333-253519, 333-262970, 333-277273 and 333-284876) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

EXHIBIT INDEX



Exhibit			Description of Exhibit

99.1			Company Announcement Dated November 19, 2025: Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.